greeksoup/ stock research
Stock research / United States / Funds / Perkins Capital Management Inc.

Perkins Capital Management Inc.

CIK 884300 · latest 13F filed 24 July 2026 · Read the filing on EDGAR

Perkins Capital Management Inc. reported 79 US-listed holdings worth $133.0 million in its 13F for the quarter ended 30 June 2026, filed 24 July 2026. Its largest: Natera Inc Com (8.3%), Eli Lilly & Co. (7.8%) and Advanced Micro Devices Inc. (6.1%). Against the quarter before, it opened 5 positions, added to 8, trimmed 45 and sold out of 12.

Reported holdings$133.0M+24.6% on Q1 2026
Positions79-7 on Q1 2026
The largest ten52.2%of its reported holdings
Latest 13FQ2 2026filed 24 July 2026
Where the money is
HeldTrimmed
NTRA8.3%LLY7.8%AMD6.1%BFLY5.5%AXGN5.1%INUV4.9%QUIK3.9%IDXX3.8%BLZE3.7%MSFT3.1%VCYT2.6%OOMA2.6%PSNL2.4%CYRX2.4%65 more37.8%

The 14 largest of its 79 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $106.6 million in 84 positions$107MQ3 24Q4 2024: $112.7 million in 81 positions$113MQ4 24Q1 2025: $94.8 million in 82 positions$94.8MQ1 25Q2 2025: $99.5 million in 83 positions$99.5MQ2 25Q3 2025: $113.5 million in 83 positions$113MQ3 25Q4 2025: $125.9 million in 91 positions$126MQ4 25Q1 2026: $106.7 million in 86 positions$107MQ1 26Q2 2026: $133.0 million in 79 positions$133MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +111.9% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
105140175210Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +111.9%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 5Added 8Held 21Trimmed 45Sold out 12
Opened: 5Added: 8Held: 21Trimmed: 45Sold out: 12

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 5

  1. Creative Realities Inc. Com CREX$1.2 million
  2. NeuroOne Medical Technologies Corporat NMTC$743,754
  3. Vida Global Inc. VIDA$700,000
  4. QT Imaging Hldgs Inc. QTI$407,000
  5. Perspective Therapeutics Inc CATX$62,062

Added to 8

  1. Crexendo Inc. CXDO+17,975 shares · +9%
  2. Perion Network Ltd PERI+8,350 shares · +5%
  3. Alphatec Hldgs Inc. ATEC+3,350 shares · +2%
  4. Trisalus Life Sciences Inc. TLSI+5,000 shares · +2%
  5. Iridex Corp. IRIX+15,500 shares · +28%
  6. Castle Biosciences Inc. CSTL+725 shares · +5%
  7. Puma Biotechnology Inc. PBYI+900 shares · +7%
  8. Owlet Inc. OWLT+400 shares · +0%

Trimmed 45

  1. Natera Inc Com NTRA-3,695 shares · -8%
  2. Quicklogic Corp. QUIK-49,085 shares · -16%
  3. Axogen Inc. AXGN-21,000 shares · -12%
  4. Advanced Micro Devices Inc. AMD-1,600 shares · -10%
  5. Veracyte, Inc. VCYT-15,375 shares · -20%
  6. Inuvo Inc. INUV-67,280 shares · -12%
  7. Butterfly Network Inc. BFLY-63,350 shares · -7%
  8. Skywater Technology Inc. SKYT-14,500 shares · -55%

and 37 more in the table below

Sold out of 12

  1. Inogen Inc. INGN$1.2 million last quarter
  2. Neuroone Med Technologies Co. NMTC$1.1 million last quarter
  3. CPS Technologies Corp. CPSH$750,187 last quarter
  4. ANI Pharmaceuticals Inc. ANIP$602,972 last quarter
  5. Eplus Inc. PLUS$376,250 last quarter
  6. Digi International Inc. DGII$353,450 last quarter
  7. Vericel Corp. VCEL$336,176 last quarter
  8. Veritone Inc. VERI$309,782 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Natera Inc Com NTRA40.6K$11.0 million8.29%-3.7K
Eli Lilly & Co. LLY8.7K$10.4 million7.83%-150
Advanced Micro Devices Inc. AMD13.9K$8.1 million6.07%-1.6K
Butterfly Network Inc. BFLY867.6K$7.3 million5.49%-63.4K
Axogen Inc. AXGN147.8K$6.8 million5.13%-21.0K
Inuvo Inc. INUV515.0K$6.5 million4.88%-67.3K
Quicklogic Corp. QUIK257.6K$5.1 million3.87%-49.1K
IDEXX Laboratories Inc. IDXX9.7K$5.1 million3.84%no change
Backblaze Inc. BLZE308.7K$4.9 million3.68%-30.3K
Microsoft Corp. MSFT11.2K$4.2 million3.13%-242
Veracyte, Inc. VCYT60.0K$3.5 million2.65%-15.4K
Ooma Inc. OOMA177.0K$3.4 million2.56%-4.3K
Personalis Inc. PSNL239.0K$3.2 million2.41%no change
Cryoport Inc. CYRX199.9K$3.1 million2.36%-3.4K
Ciena Corp. CIEN6.3K$3.1 million2.32%no change
Lemaitre Vascular Inc. LMAT25.3K$2.4 million1.83%-480
Magnite Inc. MGNI98.6K$1.9 million1.41%-20.6K
Abbott Laboratories ABT20.3K$1.8 million1.38%-402
Usio Inc. USIO700.4K$1.7 million1.31%-1.6K
Ondas Hldgs Inc. ONDS201.5K$1.7 million1.25%-500
Neogenomics Inc. NEO110.0K$1.6 million1.21%-22.3K
Perion Network Ltd PERI165.2K$1.6 million1.21%+8.3K
Neogen Corp. NEOG177.5K$1.6 million1.20%-500
Crexendo Inc. CXDO212.8K$1.6 million1.20%+18.0K
Alphatec Hldgs Inc. ATEC175.2K$1.5 million1.14%+3.4K
AbbVie Inc. ABBV5.3K$1.3 million1.00%-35
Creative Realities Inc. Com CREX300.1K$1.2 million0.93%new
Lucid Diagnostics Inc. LUCD1.1M$1.2 million0.91%-1.0K
Codexis Inc. CDXS526.1K$1.2 million0.89%-1.4K
Zeta Global Holdings Corp. ZETA55.9K$1.1 million0.83%no change
Trisalus Life Sciences Inc. TLSI235.1K$1.1 million0.80%+5.0K
Tela Bio Inc. TELA1.4M$1.0 million0.78%-43.3K
Biodesix Inc. BDSX44.6K$1.0 million0.76%-165
Safe Pro Group Inc. SPAI230.5K$998,0650.75%-750
Merck & Co., Inc. MRK7.5K$963,7500.72%-250
Gilead Sciences, Inc. GILD7.2K$911,6690.69%no change
Viatris Inc. VTRS53.8K$854,9320.64%-1.1K
Pfizer Inc. PFE33.8K$812,9170.61%-2.1K
Blacksky Technology Inc. BKSY28.8K$802,7000.60%no change
Apple Inc. AAPL2.6K$766,8040.58%no change
Profound Med Corp. Com New PROF114.3K$759,9620.57%no change
U.S. Bancorp USB12.3K$745,9400.56%-200
NeuroOne Medical Technologies Corporat NMTC244.7K$743,7540.56%new
Vida Global Inc. VIDA250.0K$700,0000.53%new
Target Corp. TGT4.8K$620,3970.47%-150
Owlet Inc. OWLT106.5K$611,2810.46%+400
Elauwit Connection Inc. ELWT55.5K$597,9350.45%no change
Mdxhealth SA MDXH1.4M$579,7220.44%-64.5K
Seagate Technology Holdings plc STX525$506,6250.38%-25
Atricure Inc. ATRC17.5K$489,6500.37%-8.6K
ConocoPhillips COP4.7K$483,4140.36%-200
NXP Semiconductors N.V. NXPI1.7K$477,7510.36%-100
Lifevantage Corp. LFVN75.5K$470,8580.35%no change
Celcuity Inc. CELC4.5K$470,7900.35%-900
General Mills Inc. GIS8.4K$434,3500.33%-500
Skywater Technology Inc. SKYT11.9K$414,3580.31%-14.5K
Bristol-Myers Squibb Co. BMY7.2K$413,7120.31%-250
Donaldson Co. Inc. DCI4.6K$412,9420.31%no change
QT Imaging Hldgs Inc. QTI100.0K$407,0000.31%new
Verizon Communications Inc. VZ9.1K$385,6330.29%no change
Castle Biosciences Inc. CSTL16.1K$384,9390.29%+725
Aziyo Biologic ELUT694.1K$379,9340.29%-62.8K
Fastenal Co. FAST7.2K$348,2170.26%no change
AT&T Inc. T16.0K$331,0340.25%no change
BP plc BP8.7K$319,6170.24%-550
Johnson & Johnson JNJ1.2K$304,7640.23%no change
Beeline Holdings Inc. BLNE238.0K$290,3600.22%-7.0K
Moderna, Inc. MRNA4.0K$280,1200.21%no change
Exagen Inc. XGN56.8K$264,1010.20%-15.0K
Apyx Medical Corporation APYX42.0K$188,5800.14%no change
Airgain Inc. AIRG22.0K$138,6000.10%no change
Puma Biotechnology Inc. PBYI13.4K$108,6740.08%+900
OptimizeRx Corp OPRX14.8K$84,7020.06%-1.1K
Iridex Corp. IRIX70.8K$81,0660.06%+15.5K
Perspective Therapeutics Inc CATX18.2K$62,0620.05%new
Sophia Genetics SA SOPH10.5K$60,5850.05%no change
Pulmonx Corp. LUNG39.5K$51,3500.04%-1.5K
Dyadic Intl Inc. Del DYAI48.0K$43,0530.03%no change
Accuray Inc. ARAY20.0K$5,1560.00%-32.5K
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 12 it sold out of are in the box above.